Health Matters
Printing is not available for Health Matters content.
Subscribers can read every article in full at health-matters.io.

Enzalutamide

04.03.2025

The University of California's (UC) patent for Xtandi, a prostate cancer drug, was revoked in South Africa, allowing generic alternatives to enter the market.

Search the archive

Browse by month